These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8997600)

  • 1. Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model.
    Papp M; Moryl E; Maccecchini ML
    Eur J Pharmacol; 1996 Dec; 317(2-3):191-6. PubMed ID: 8997600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats.
    Papp M; Moryl E
    Pol J Pharmacol; 1994; 46(1-2):79-81. PubMed ID: 7981776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wojcik E
    Neuropharmacology; 1997 Jan; 36(1):31-7. PubMed ID: 9144639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites.
    Coderre TJ; Van Empel I
    Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
    Tzschentke TM; Schmidt WJ
    Neurosci Lett; 1995 Jun; 193(1):37-40. PubMed ID: 7566661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats.
    Zajaczkowski W; Moryl E; Papp M
    Pharmacol Biochem Behav; 1996 Sep; 55(1):163-8. PubMed ID: 8870053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.
    Geter-Douglass B; Witkin JM
    Psychopharmacology (Berl); 1997 Sep; 133(1):43-50. PubMed ID: 9335079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.
    Trullas R; Skolnick P
    Eur J Pharmacol; 1990 Aug; 185(1):1-10. PubMed ID: 2171955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
    Wlaź P; Ebert U; Löscher W
    Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.
    Marcus MM; Mathé JM; Nomikos GG; Svensson TH
    Neuropharmacology; 2001 Mar; 40(4):482-90. PubMed ID: 11249957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
    Bienkowski P; Stefanski R; Kostowski W
    Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.
    Boje KM; Lakhman SS
    Neurochem Res; 1998 Sep; 23(9):1167-74. PubMed ID: 9712186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.